Skip to main content
OpenTrials
Completed

NCT Number: NCT01621347

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infection Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Health Behavior Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Medication Adherence Patient Acceptance of Health Care Patient Compliance Pregnancy RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Treatment Adherence and Compliance Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Policlinique Médicale Universitaire

Lausanne, Canton of Vaud, 1011, Switzerland

About this study

Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care & community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant Women
  • HIV-positive
  • Antiretroviral medication delivered in electronical monitors

Exclusion criteria

  • Monitored period during pregnancy < 1 month

Treatment and study plan

Primary outcomes

  1. Change in patient adherence during pregnancy and postpartum

    Time frame: before delivery (1 to 9 month) and postpartum (6 month)

    By electronic drug monitoring, pill count and subject interviews' marks

Secondary outcomes

  1. Adherence barriers and facilitators

    Time frame: pregnancy and postpartum (6 months)

    Data recorded in subject's interview marks

Sponsors and collaborators

Lead sponsor

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Other

Collaborators

  • Centre Hospitalier Universitaire Vaudois
  • Swiss HIV Cohort Study

Registry information

Official study title

Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jun 18, 2012
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.